United States · FDA National Drug Code directory
Midazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-2596_6c075a2d-b68b-41a7-aa0c-bcf9894e3f76
- Product NDC
- 0409-2596
- Form
- INJECTION, SOLUTION
- Composition / generic term
- MIDAZOLAM HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20051103
- Source listing expiry
- 20271231
Source-listed ingredients
- MIDAZOLAM HYDROCHLORIDE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, MULTI-DOSE in 1 CARTON (0409-2596-03) / 5 mL in 1 VIAL, MULTI-DOSE (0409-2596-13) · 0409-2596-03
- 10 VIAL, MULTI-DOSE in 1 CARTON (0409-2596-05) / 10 mL in 1 VIAL, MULTI-DOSE (0409-2596-15) · 0409-2596-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →